ICAM1 and type 2 diabetes mellitus: Based on our analysis, VCAM-1 and ICAM-1 mRNAs were significantly increased in T2D pulmonary ECs compared to the control group (P < 0.01 and P < 0.001 respectively;Figure 3a, b).